Volume 19, Number 1—January 2013
Dispatch
Klebsiella pneumoniae Antimicrobial Drug Resistance, United States, 1998–2010
Guillermo V. Sanchez, Ronald N. Master, Richard B. Clark, Madiha Fyyaz, Padmaraj Duvvuri, Gupta Ekta, and Jose Bordon
Table 2
Klebsiella pneumoniae antimicrobial drug resistance rates, United States, 2010*
| Source, no. samples | AMK | GEN | TOB | TZP | ATM | IPM | CAZ | CRO | CPM | TMP/SXT | CIP | TET |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All, 187,359 | 4.5 | 9.2 | 13.8 | 12.7 | 22.2 | 4.3 | 17.2 | 12.1 | 7.7 | 19.3 | 16.8 | 16.7 |
| Blood, 20,185 | 4.2 | 10.6 | 14.9 | 15 | 23.6 | 5.9 | 19.2 | 13.4 | 7.1 | 21.3 | 18.9 | 17.1 |
| Urine, 112,567 | 4.1 | 7.8 | 12.4 | 10.6 | 21 | 3.8 | 15.1 | 10.9 | 7.1 | 18.3 | 15.1 | 17.3 |
| Wound, 22,225 | 4.5 | 10.1 | 14.4 | 14.7 | 20.9 | 5 | 17.5 | 12.2 | 8.3 | 19.5 | 16.8 | 16.4 |
| Respiratory, 32,382 | 5.8 | 11.1 | 15.8 | 16.4 | 24.5 | 4.7 | 21.3 | 15.5 | 9.9 | 20.2 | 20 | 15.5 |
*AMK, amikacin; GEN, gentamicin; TOB, tobramycin; TZP, piperacillin/tazobactam; ATM, aztreonam; IPM, imipenem; CAZ, ceftazidime; CRO, ceftriaxone; CPM, cefepime; TMP/SXT, trimethoprim/sulfamethoxazole; CIP, ciprofloxacin; TET, tetracycline.
Page created: December 20, 2012
Page updated: December 20, 2012
Page reviewed: December 20, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.